Skip to content [s] Site map [3] Home [1]
Graphic text

Am I Eligible?

Educational Scholarship Program (ESP) Requirements:

  • Have (and maintain) a solid academic record, especially in math and science
  • Furnish most recent transcript or report card
  • Be 17 years of age or older on or before May 1
  • If a high school student, attend a Houston-area public or private school
  • Secure a recommendation letter from a guidance counselor/advisor or science teacher/professor
  • Have reliable transportation
  • Have the consent of a parent or guardian to participate

Application and Deadlines

Please download the Scholarship Program Application and submit by mail as indicated on the form. The form may be submitted between September 1 and January 31 for participation in the program the following summer. After you submit your application, please send all required supporting documents (listed above, in the program requirements) as soon as possible by regular mail to:

CHRISTUS Stehlin Foundation
ATTN: Scholarship Program
10301 Stella Link Rd Ste A
Houston TX 77025-5447

The Foundation will consider ONLY those applications complete with all supporting documents.

Acceptance and Notification

Applications are reviewed each spring. All applicants will be notified of the Foundation’s decision by email and letter on or before March 15. Depending on school terms, successful applicants typically begin work about June 1 and continue through mid-August.

In considering applicants currently attending college, preference is given to students with declared majors in science and technology. Also, first time applications usually receive preference for both high school and college students.


If you have questions about the Foundation’s Educational Scholarship Program, contact us by email or by phone at 713-659-1336. We look forward to receiving your application, and wish you success in your academic (and your scientific) career!

Reasons for Hope

Compared with other anticancer drugs at similar stages of development, camptothecins have demonstrated a much higher anticancer activity. Camptothecins can be envisioned as the ultimate anticancer drug when fully developed.”

National Academy of Science, 1995


Two Houston CHRISTUS Hospitals and Stehlin Soon to Join Houston Methodist

CHRISTUS Stehlin Foundation for Cancer Research will join CHRISTUS St. Catherine and CHRISTUS St. John in a new partnership with Houston Methodist.

Nearly 14 Million Cancer Survivors in U.S.

There are currently 13.7 million cancer survivors in the United States and the number is expected to rise by 31 percent to 18 million by 2022, according to a new report. >> Click article title for more.

All News

Share this Page

Stay Connected

Button Button Button Button

Get Hope!

Sign up for our newsletter and updates.

CHRISTUS Stehlin Foundation for Cancer Research

10301 Stella Link Road, Suite A
Houston, Texas 77025-5447

Affiliates and Resources

Logo Logo Logo Logo Logo